These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1406777)

  • 21. Duchenne muscular dystrophy.
    Matsuo M
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():166-71. PubMed ID: 8629099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of deletion mutations of the dystrophin gene by the multiplex polymerase chain reaction method in the diagnosis of Duchenne muscular dystrophy].
    Baranov Vs; Gorbunova VN; Malysheva OV; Krasil'nikov VV
    Mol Gen Mikrobiol Virusol; 1991 Sep; (9):13-5. PubMed ID: 1745268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe.
    Matsuo M; Masumura T; Nishio H; Nakajima T; Kitoh Y; Takumi T; Koga J; Nakamura H
    J Clin Invest; 1991 Jun; 87(6):2127-31. PubMed ID: 2040695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer.
    Morandi L; Bernasconi P; Gebbia M; Mora M; Crosti F; Mantegazza R; Cornelio F
    Neuromuscul Disord; 1995 Jul; 5(4):291-5. PubMed ID: 7580241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiplex PCR to detect the dystrophin gene deletion in Thai patients.
    Mutirangura A; Jongpiputvanich S; Norapucsunton T; Theamboonlers A; Srivuthana S; Promchainant C; Tumwasorn S; Sueblinvong T
    J Med Assoc Thai; 1995 Sep; 78(9):460-5. PubMed ID: 7561572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy for muscular disease.
    Johnston N
    Drug Discov Today; 2004 Sep; 9(18):777. PubMed ID: 15364061
    [No Abstract]   [Full Text] [Related]  

  • 27. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
    Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin.
    Le Thiet Thanh ; Nguyen Thi Man ; Hori S; Sewry CA; Dubowitz V; Morris GE
    Am J Med Genet; 1995 Aug; 58(2):177-86. PubMed ID: 8533812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A method to codetect introduced genes and their products in gene therapy protocols.
    Gussoni E; Wang Y; Fraefel C; Miller RG; Blau HM; Geller AI; Kunkel LM
    Nat Biotechnol; 1996 Aug; 14(8):1012-6. PubMed ID: 9631042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional enhancement of skeletal muscle by gene transfer.
    Gregorevic P; Chamberlain JS
    Phys Med Rehabil Clin N Am; 2005 Nov; 16(4):875-87, vii-viii. PubMed ID: 16214049
    [No Abstract]   [Full Text] [Related]  

  • 31. Patient page. Gene therapy and muscular dystrophies.
    Karceski S
    Neurology; 2008 Jul; 71(4):e6-8. PubMed ID: 18645160
    [No Abstract]   [Full Text] [Related]  

  • 32. Transcriptional profiles from patients with dystrophinopathies and limb girdle muscular dystrophies as determined by qRT-PCR.
    Arning L; Jagiello P; Schara U; Vorgerd M; Dahmen N; Gencikova A; Mortier W; Epplen JT; Gencik M
    J Neurol; 2004 Jan; 251(1):72-8. PubMed ID: 14999492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myoblast transfer and gene therapy in muscular dystrophies.
    Pagel CN; Morgan JE
    Microsc Res Tech; 1995 Apr; 30(6):469-79. PubMed ID: 7599358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Southern blot and PCR analyses of dystrophin gene deletions in Japanese patients with Duchenne muscular dystrophy.
    Nakajima T; Matsuo M; Nakamura H; Fujiwara Y
    Kobe J Med Sci; 1991 Feb; 37(1):21-33. PubMed ID: 1921260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-efficiency plasmid gene transfer into dystrophic muscle.
    Gollins H; McMahon J; Wells KE; Wells DJ
    Gene Ther; 2003 Mar; 10(6):504-12. PubMed ID: 12621454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients.
    Shomrat R; Gluck E; Legum C; Shiloh Y
    Am J Med Genet; 1994 Feb; 49(4):369-73. PubMed ID: 8160727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of DMD gene deletions in Thai children patients.
    Kamolsilp M; Paditaporn R; Noonai A; Wasant P
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():172-4. PubMed ID: 8629100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A missense mutation in the dystrophin gene in a Duchenne muscular dystrophy patient.
    Prior TW; Papp AC; Snyder PJ; Burghes AH; Bartolo C; Sedra MS; Western LM; Mendell JR
    Nat Genet; 1993 Aug; 4(4):357-60. PubMed ID: 8401582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two distinct mutations in a single dystrophin gene: identification of an altered splice-site as the primary Becker muscular dystrophy mutation.
    Wilton SD; Johnsen RD; Pedretti JR; Laing NG
    Am J Med Genet; 1993 Jun; 46(5):563-9. PubMed ID: 8322822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
    Matsumura K; Campbell KP
    Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.